Clinical Trials · NCT01722240

Liraglutide in Type 1 Diabetes

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
University at Buffalo
Enrollment
69
Start date
Nov 2012
Locations
1 site, United States
Primary endpoint
HbA1c (%)
View Liraglutide compound reference